Project Number 1R01AG061122-01 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL OF T3D-959 IN MILD TO MODERATE ALZHEIMER'S DISEASE SUBJECTS